WallStreetZenWallStreetZen

NASDAQ: URGN
Urogen Pharma Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

URGN past revenue growth

How has URGN's revenue growth performed historically?
Company
28.52%
Industry
144.63%
Market
17.55%
URGN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
URGN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
URGN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

URGN earnings and revenue history

Current Revenue
$82.7M
Current Earnings
-$102.2M
Current Profit Margin
-123.6%

URGN Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when URGN announces earnings.

URGN Return on Assets

Current Company
-70.5%
Current Industry
2.9%
URGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

URGN Return on Capital Employed

Current Company
-56.84%
Current Industry
19.5%
URGN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

URGN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
URGN$82.71M-$81.90M-$102.24M+136.08%N/A
CELC$0.00-$58.31M-$63.78MN/AN/A
PROK$0.00-$25.61M-$35.47MN/AN/A
ALLO$95.00k-$313.07M-$327.27M-97.11%N/A
ABUS$18.14M-$70.99M-$72.85M+25.00%N/A
View Top Biotech Stocks

URGN earnings dates

Next earnings date
May 9, 2024

Urogen Pharma Earnings & Revenue FAQ

What were URGN's earnings last quarter?

On Invalid Date, Urogen Pharma (NASDAQ: URGN) reported Q4 2023 earnings per share (EPS) of -$0.66, up 47.2% year over year. Total Urogen Pharma earnings for the quarter were -$26.02 million. In the same quarter last year, Urogen Pharma's earnings per share (EPS) was -$1.25.

If you're new to stock investing, here's how to buy Urogen Pharma stock.

What was URGN's earnings growth in the past year?

As of Q2 2024, Urogen Pharma's earnings has grown year over year. Urogen Pharma's earnings in the past year totalled -$102.24 million.

What is URGN's earnings date?

Urogen Pharma's earnings date is Invalid Date. Add URGN to your watchlist to be reminded of URGN's next earnings announcement.

What was URGN's revenue last quarter?

On Invalid Date, Urogen Pharma (NASDAQ: URGN) reported Q4 2023 revenue of $23.53 million up 30.06% year over year. In the same quarter last year, Urogen Pharma's revenue was $18.09 million.

What was URGN's revenue growth in the past year?

As of Q2 2024, Urogen Pharma's revenue has grown 28.52% year over year. This is 116.11 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Urogen Pharma's revenue in the past year totalled $82.71 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.